Australia's leading csf platform. Everyone should have the opportunity to invest in the companies they love.

I wanted to give a clearer view of where our current valuation sits compared to what larger groups are paying for respiratory and sleep-related assets. The entry point This round is priced at a...

Secondary markets that de-risk the BioAnalytics opportunity. We developed a strategy to protect investors by ensuring there are secondary markets for its products. In addition to the core sleep...

nvestment Opportunity: BioAnalytics - Solving the $150 Billion Sleep Apnea Problem The sleep apnea market is a rare, defensive growth sector where companies trade at massive premiums, exemplified...

Happy Friday to everyone on the Birchal Platform. We are so grateful to those of you who have joined us and are looking forward to more investors joining our business to save our oceans. One of...

Investor Update: Sleep Apnea’s Hidden Comorbidities – And Why They Matter for BioAnalytics Obstructive sleep apnea (OSA) is often seen as a “sleep issue”. In reality, it sits at the centre of a web...

It's not often you find an identified unserved market that's $3 billion per annum, growing at 8% CAGR. Our strategy to reward investors is to complete the independent trial and then run a...

How to Fit the BioAnalytics Sleep Apnea Device (and How It Compares) in 2 Minutes

With our public offer officially opened, we thought we'd share a little story about how we got started. The foundation of Reef Craft began with a kitchen conversation back in 2018 between our...